Attune Pharmaceuticals Overview
- Year Founded
-
2017
- Status
-
Private
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$23.3M
- Investors
-
7
Attune Pharmaceuticals General Information
Description
Developer of orally administered small molecule therapeutics designed for the treatment of rare diseases. The company offers small molecule drug development and serine protease targeting approaches to create targeted therapies for rare and underserved diseases, enabling patients with rare disease conditions and healthcare providers to access treatments that improve disease management and clinical outcomes.
Contact Information
Website
attunepharmaceutical.comCorporate Office
- 250 West 55th Street
- 34th Floor
- New York, NY 10019
- United States
Corporate Office
- 250 West 55th Street
- 34th Floor
- New York, NY 10019
- United States
Attune Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Early Stage VC (Series B) | 23-Jan-2019 | $23.3M | Completed | Clinical Trials - Phase 1 | ||
| 1. Early Stage VC (Series A) | Completed | Startup |
Attune Pharmaceuticals Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Attune Pharmaceuticals Comparisons
Industry
Financing
Details
Attune Pharmaceuticals Competitors (68)
One of Attune Pharmaceuticals’s 68 competitors is Klotho Therapeutics, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Klotho Therapeutics | Formerly VC-backed | San Diego, CA | ||||
| ABIONYX Pharma | Formerly VC-backed | Balma, France | ||||
| Altimmune | Formerly VC-backed | Gaithersburg, MD | ||||
| Cour | Venture Capital-Backed | Skokie, IL | ||||
| Xenetic Biosciences | Corporation | Framingham, MA |
Attune Pharmaceuticals Patents
Attune Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019227866-A1 | Treatment of hereditary angioedema | Inactive | 28-Feb-2018 | ||
| CA-3092538-A1 | Treatment of hereditary angioedema | Inactive | 28-Feb-2018 | ||
| EP-3758702-A1 | Treatment of hereditary angioedema | Inactive | 28-Feb-2018 | ||
| EP-3758702-A4 | Treatment of hereditary angioedema | Inactive | 28-Feb-2018 | ||
| US-20200405708-A1 | Treatment of hereditary angioedema | Inactive | 28-Feb-2018 | A61P7/10 |
Attune Pharmaceuticals Investors (7)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Boxer Capital | Corporate Venture Capital | Minority | ||
| LifeSci Venture Partners | Corporate Venture Capital | Minority | ||
| RA Capital Management | Asset Manager | Minority | ||
| RTW Investments | Hedge Fund | Minority | ||
| Tang Capital Management | Venture Capital | Minority |
Attune Pharmaceuticals FAQs
-
When was Attune Pharmaceuticals founded?
Attune Pharmaceuticals was founded in 2017.
-
Where is Attune Pharmaceuticals headquartered?
Attune Pharmaceuticals is headquartered in New York, NY.
-
What industry is Attune Pharmaceuticals in?
Attune Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Attune Pharmaceuticals a private or public company?
Attune Pharmaceuticals is a Private company.
-
What is the current valuation of Attune Pharmaceuticals?
The current valuation of Attune Pharmaceuticals is .
-
What is Attune Pharmaceuticals’s current revenue?
The current revenue for Attune Pharmaceuticals is .
-
How much funding has Attune Pharmaceuticals raised over time?
Attune Pharmaceuticals has raised $30.8M.
-
Who are Attune Pharmaceuticals’s investors?
Boxer Capital, LifeSci Venture Partners, RA Capital Management, RTW Investments, and Tang Capital Management are 5 of 7 investors who have invested in Attune Pharmaceuticals.
-
Who are Attune Pharmaceuticals’s competitors?
Klotho Therapeutics, ABIONYX Pharma, Altimmune, Cour, and Xenetic Biosciences are some of the 68 competitors of Attune Pharmaceuticals.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process